G855-3371 Screening compound: 1-cyclobutanecarbonyl-6-{[4-(2-methyl-2,3-dihydro-1H-indole-1-carbonyl)piperidin-1-yl]sulfonyl}-1,2,3,4-tetrahydroquinoline

G855-3371 Screening compound: 1-cyclobutanecarbonyl-6-{[4-(2-methyl-2,3-dihydro-1H-indole-1-carbonyl)piperidin-1-yl]sulfonyl}-1,2,3,4-tetrahydroquinoline
G855-3371 Screening compound: 1-cyclobutanecarbonyl-6-{[4-(2-methyl-2,3-dihydro-1H-indole-1-carbonyl)piperidin-1-yl]sulfonyl}-1,2,3,4-tetrahydroquinoline alternative view

Chemical Structure Depiction of ChemDiv screening compound G855-3371
1-cyclobutanecarbonyl-6-{[4-(2-methyl-2,3-dihydro-1H-indole-1-carbonyl)piperidin-1-yl]sulfonyl}-1,2,3,4-tetrahydroquinoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G855-3371

Molecular Formula

C29H35N3O4S (C29 H35 N3 O4 S)

Compound Name

1-cyclobutanecarbonyl-6-{[4-(2-methyl-2,3-dihydro-1H-indole-1-carbonyl)piperidin-1-yl]sulfonyl}-1,2,3,4-tetrahydroquinoline

IUPAC name

1-cyclobutanecarbonyl-6-{[4-(2-methyl-23-dihydro-1H-indole-1-carbonyl)piperidin-1-yl]sulfonyl}-1234-tetrahydroquinoline

SMILES

CC(C1)N(C(C(CC2)CCN2S(c(cc2)cc(CCC3)c2N3C(C2CCC2)=O)(=O)=O)=O)c2c1cccc2

InChI

InChI=1S/C29H35N3O4S/c1-20-18-23-6-2-3-10-27(23)32(20)29(34)22-13-16-30(17-14-22)37(35,36)25-11-12-26-24(19-25)9-5-15-31(26)28(33)21-7-4-8-21/h2-3,6,10-12,19-22H,4-5,7-9,13-18H2,1H3/t20-/m0/s1

InChI Key

BJYPBWUQRHTIPG-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD15041340

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

521.68

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.743

Distribution Coefficient, logD

3.743

Water Solubility, LogSw

-3.99

Polar Surface Area

62.403

Acid Dissociation Constant (pKa)

22.05

Base Dissociation Constant (pKb)

-0.16

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

51.70

G855-3371 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G855-3371 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G855-3371?
Check Price and Availability of G855-3371, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G855-3371 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G855-3371
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G855-3371
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G855-3371 available by request